Turkish and Moroccan Dutch women's views of using a self-sampling kit for human papillomavirus testing as a tool for cervical cancer screening: What are the barriers and the motivators?

被引:1
|
作者
Hilverda, Femke [1 ]
Fissers, Katleen [1 ]
van den Broek, Thijs [1 ]
机构
[1] Erasmus Univ, Erasmus Sch Hlth Policy & Management, Dept Sociomed Sci, POB 1738, NL-3000 DR Rotterdam, Netherlands
关键词
cervical cancer screening; HPV; self-sampling; theory of planned behavior; Turkish and Moroccan Dutch women; FOCUS GROUPS; NON-ATTENDANCE; VACCINE UPTAKE; RISK; NETHERLANDS; PROGRAMS; BEHAVIOR; REASONS;
D O I
10.1177/17455065211065873
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective: This study explores barriers and motivators to use self-sampling kits for human papillomavirus testing for cervical cancer screening as perceived by Dutch women of Turkish and Moroccan origin living in the Netherlands. Methods: A total of II in-depth semi-structured interviews were conducted and structured according to the theory of planned behavior. Results: Findings suggest that self-sampling may lift important barriers hampering traditional cervical cancer screening, such as those related to shame and chastity. However, self-sampling raises its own barriers too. Most importantly, some women fear that self-sampling may harm virginity. Some women also do not feel confident about their ability to properly use the self-sampling kit, but fears about the inability to properly use it often fade away upon having seen the self-sampling kit. Moreover, results show that knowledge about cervical cancer and its origin is limited, which may undermine women's willingness to participate in a screening program. Conclusions: These results suggest that communication strategies to encourage using self-sampling kits among women of Turkish and Moroccan origin could benefit from culturally sensitive approaches, for example, by placing emphasis on issues such as virginity and chastity. Consistent with a recent advice of the Health Council of the Netherlands, the kit could furthermore be sent to eligible women as a standard procedure, rather than upon request. This could reduce hassle and doubts about women's ability to use the self-sampling kit. Finally, educating women about the importance of screening to prevent cervical cancer is needed to foster informed decision-making.
引用
收藏
页数:11
相关论文
共 50 条
  • [41] Acceptability of self-sampling human papillomavirus test for cervical cancer screening in Japan: A questionnaire survey in the ACCESS trial
    Fujita, Misuzu
    Nagashima, Kengo
    Shimazu, Minobu
    Suzuki, Misae
    Tauchi, Ichiro
    Sakuma, Miwa
    Yamamoto, Setsuko
    Hanaoka, Hideki
    Shozu, Makio
    Tsuruoka, Nobuhide
    Kasai, Tokuzo
    Hata, Akira
    PLOS ONE, 2023, 18 (06):
  • [42] The Mexican Cervical Cancer Screening Trial Self-Sampling for Human Papillomavirus With Unaided Visual Inspection as a Secondary Screen
    Belinson, Jerome L.
    Pretorius, Robert G.
    Enerson, Christine
    Garcia, Francisco
    Perez Cruz, Eduardo
    Belinson, Suzanne E.
    Yeverino Garcia, Eduardo
    Brainard, Jennnifer
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2009, 19 (01) : 27 - 32
  • [43] Economic Evaluation of Mailed Home-Based Human Papillomavirus Self-sampling Kits for Cervical Cancer Screening
    Meenan, Richard T.
    Troja, Catherine
    Buist, Diana S. M.
    Tiro, Jasmin A.
    Lin, John
    Anderson, Melissa L.
    Gao, Hongyuan
    Green, Beverly B.
    Winer, Rachel L.
    JAMA NETWORK OPEN, 2023, 6 (03) : E234052
  • [44] Strategies to Increase Cervical Cancer Screening With Mailed Human Papillomavirus Self-Sampling Kits: A Randomized Clinical Trial
    Winer, Rachel L.
    Lin, John
    Anderson, Melissa L.
    Tiro, Jasmin A.
    Green, Beverly B.
    Gao, Hongyuan
    Meenan, Richard T.
    Hansen, Kristina
    Sparks, Angela
    Buist, Diana S. M.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2023, 330 (20): : 1971 - 1981
  • [45] Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France
    Laura Reques
    Camille Rolland
    Anne Lallemand
    Najat Lahmidi
    Ezequiel Aranda-Fernández
    Antonio Lazzarino
    Julie Bottero
    Françoise Hamers
    Christine Bergeron
    Ken Haguenoer
    Guy Launoy
    Niklas Luhmann
    BMC Women's Health, 21
  • [46] Comparison of cervical cancer screening by self-sampling papillomavirus test versus pap-smear in underprivileged women in France
    Reques, Laura
    Rolland, Camille
    Lallemand, Anne
    Lahmidi, Najat
    Aranda-Fernandez, Ezequiel
    Lazzarino, Antonio
    Bottero, Julie
    Hamers, Francoise
    Bergeron, Christine
    Haguenoer, Ken
    Launoy, Guy
    Luhmann, Niklas
    BMC WOMENS HEALTH, 2021, 21 (01)
  • [47] Mailing human papillomavirus self-sampling kits to women under-screened for cervical cancer improved detection in cervical cancer screening in a general population study in Japan
    Nishimura, Yoko
    Matsuura, Motoki
    Terada, Noriko
    Nagao, Sachiko
    Shimada, Hiroshi
    Isoyama, Kyoko
    Tamate, Masato
    Iwasaki, Masahiro
    Saito, Tsuyoshi
    BMC PUBLIC HEALTH, 2023, 23 (01)
  • [48] Acceptability of vaginal self-sampling with high-risk human papillomavirus testing for cervical cancer screening: a French questionnaire-based study
    Bertucci, Martina
    Bonnet, Emmanuel
    Satger, Laura
    Kreiche, Antoine
    Chappert, Jean-Loup
    Loy-Morel, Silvia
    Segondy, Michel
    Daures, Jean Pierre
    Boulle, Nathalie
    WOMEN & HEALTH, 2021, 61 (01) : 83 - 94
  • [49] Mailing human papillomavirus self-sampling kits to women under-screened for cervical cancer improved detection in cervical cancer screening in a general population study in Japan
    Yoko Nishimura
    Motoki Matsuura
    Noriko Terada
    Sachiko Nagao
    Hiroshi Shimada
    Kyoko Isoyama
    Masato Tamate
    Masahiro Iwasaki
    Tsuyoshi Saito
    BMC Public Health, 23
  • [50] Acceptability of self-sampling and human papillomavirus testing among non-attenders of cervical cancer screening programs in E1 Salvador
    Maza, M.
    Melendez, M.
    Masch, R.
    Alfaro, K.
    Chacon, A.
    Gonzalez, E.
    Soler, M.
    Conzuelo-Rodriguez, G.
    Gage, J. C.
    Alonzo, T. A.
    Castle, P. E.
    Felix, J. C.
    Cremer, M.
    PREVENTIVE MEDICINE, 2018, 114 : 149 - 155